Virginia King's experience highlights a troubling reality: after her diagnosis, she received a bill significantly exceeding the actual drug price, revealing discrepancies in hospital billing practices.
The program designed to help a select group of safety-net providers has expanded dramatically, with over half of nonprofit hospitals now participating, raising ethical concerns about profitability.
Studies indicate that, rather than reducing costs, the proliferation of this program has actually contributed to rising health care expenses for patients, employers, and taxpayers.
While some argue that the program sustains essential health services, many large nonprofit systems appear to be prioritizing financial gain over patient care.
Collection
[
|
...
]